Invesco Ltd. Ampio Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.16 - $0.47 $10,495 - $30,830	-65,597 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $682 - $1,006	-1,624 Reduced 2.42%	65,597 $31,000
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $25,158 - $76,821	-44,925 Reduced 40.06%	67,221 $38,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.8 $34,749 - $51,694	28,719 Added 34.42%	112,146 $187,000
Q2 2021 Aug 17, 2021	BUY	$1.56 - $1.98 $130,146 - $165,185	83,427 New	83,427 $139,000
Q1 2019 May 15, 2019	SELL	$0.43 - $0.68 $15,820 - $25,019	-36,793 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.39 - $0.7 $14,349 - $25,755	36,793 New	36,793 $15,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.